scholarly journals β-Secretase-1 elevation in aged monkey and Alzheimer’s disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation

2010 ◽  
Vol 32 (7) ◽  
pp. 1223-1238 ◽  
Author(s):  
Yan Cai ◽  
Kun Xiong ◽  
Xue-Mei Zhang ◽  
Huaibin Cai ◽  
Xue-Gang Luo ◽  
...  
Neuron ◽  
2001 ◽  
Vol 30 (3) ◽  
pp. 665-676 ◽  
Author(s):  
Robert A Cherny ◽  
Craig S Atwood ◽  
Michel E Xilinas ◽  
Danielle N Gray ◽  
Walton D Jones ◽  
...  

Cell Calcium ◽  
2011 ◽  
Vol 49 (4) ◽  
pp. 208-216 ◽  
Author(s):  
Sophie Sokolow ◽  
Sanh H. Luu ◽  
Alison J. Headley ◽  
Alecia Y. Hanson ◽  
Taeree Kim ◽  
...  

2021 ◽  
Vol 15 ◽  
Author(s):  
Guimei Zhang ◽  
Zicheng Wang ◽  
Huiling Hu ◽  
Meng Zhao ◽  
Li Sun

Alzheimer’s disease (AD) is one of the most common types of age-related dementia worldwide. In addition to extracellular amyloid plaques and intracellular neurofibrillary tangles, dysregulated microglia also play deleterious roles in the AD pathogenesis. Numerous studies have demonstrated that unbridled microglial activity induces a chronic neuroinflammatory environment, promotes β-amyloid accumulation and tau pathology, and impairs microglia-associated mitophagy. Thus, targeting microglia may pave the way for new therapeutic interventions. This review provides a thorough overview of the pathophysiological role of the microglia in AD and illustrates the potential avenues for microglia-targeted therapies, including microglial modification, immunoreceptors, and anti-inflammatory drugs.


Cell Reports ◽  
2020 ◽  
Vol 32 (12) ◽  
pp. 108169 ◽  
Author(s):  
Jinjing Yao ◽  
Bo Sun ◽  
Adam Institoris ◽  
Xiaoqin Zhan ◽  
Wenting Guo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document